IVHN Stock Overview
Engages in the exploration and evaluation of mineral properties in Australia, Peru, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Nubian Resources Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.027 |
| 52 Week High | CA$0.049 |
| 52 Week Low | CA$0.006 |
| Beta | 0.87 |
| 11 Month Change | 20.00% |
| 3 Month Change | -6.90% |
| 1 Year Change | 17.39% |
| 33 Year Change | -83.93% |
| 5 Year Change | -60.00% |
| Change since IPO | -99.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVHN | DE Metals and Mining | DE Market | |
|---|---|---|---|
| 7D | -5.3% | 0.1% | -1.0% |
| 1Y | 17.4% | -30.8% | 12.8% |
Return vs Industry: IVHN exceeded the German Metals and Mining industry which returned -30.8% over the past year.
Return vs Market: IVHN exceeded the German Market which returned 12.8% over the past year.
Price Volatility
| IVHN volatility | |
|---|---|
| IVHN Average Weekly Movement | 49.2% |
| Metals and Mining Industry Average Movement | 5.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IVHN's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: IVHN's weekly volatility has decreased from 68% to 49% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Martin Walter | www.nubianr.com |
Nubian Resources Ltd. engages in the exploration and evaluation of mineral properties in Australia, Peru, and the United States. It explores for gold, silver, lead, copper, and zinc deposits. The company was formerly known as ICS Copper Systems Ltd.
Nubian Resources Ltd. Fundamentals Summary
| IVHN fundamental statistics | |
|---|---|
| Market cap | €2.72m |
| Earnings (TTM) | -€245.14k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-11.1x
P/E RatioIs IVHN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVHN income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | -CA$24.23k |
| Gross Profit | CA$24.23k |
| Other Expenses | CA$390.72k |
| Earnings | -CA$366.48k |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0054 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did IVHN perform over the long term?
See historical performance and comparison